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Abstract
Background: Transcriptome data from quantitative PCR (Q-PCR) and DNA microarrays are
typically obtained from a fixed amount of RNA collected per sample. Therefore, variations in tissue
cellularity and RNA yield across samples in an experimental series compromise accurate
determination of the absolute level of each mRNA species per cell in any sample. Since mRNAs are
copied from genomic DNA, the simplest way to express mRNA level would be as copy number
per template DNA, or more practically, as copy number per cell.
Results: Here we report a method (designated the "Percellome" method) for normalizing the
expression of mRNA values in biological samples. It provides a "per cell" readout in mRNA copy
number and is applicable to both quantitative PCR (Q-PCR) and DNA microarray studies. The
genomic DNA content of each sample homogenate was measured from a small aliquot to derive
the number of cells in the sample. A cocktail of five external spike RNAs admixed in a dose-graded
manner (dose-graded spike cocktail; GSC) was prepared and added to each homogenate in
proportion to its DNA content. In this way, the spike mRNAs represented absolute copy numbers
per cell in the sample. The signals from the five spike mRNAs were used as a dose-response
standard curve for each sample, enabling us to convert all the signals measured to copy numbers
per cell in an expression profile-independent manner. A series of samples was measured by Q-PCR
and Affymetrix GeneChip microarrays using this Percellome method, and the results showed up to
90 % concordance.
Conclusion: Percellome data can be compared directly among samples and among different
studies, and between different platforms, without further normalization. Therefore, "percellome"
normalization can serve as a standard method for exchanging and comparing data across different
platforms and among different laboratories.
Background
Normalization of gene expression data between different
samples generated in the same laboratory using a single
platform, and/or generated in different geographical
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regions using multiple platforms, is central to the estab-
lishment of a reliable reference database for toxicogenom-
ics and pharmacogenomics. Transforming expression data
into a "per cell" database is an effective way of normaliz-
ing expression data across samples and platforms. How-
ever, transcriptome data from the quantitative PCR (Q-
PCR) and DNA microarray analyses currently deposited in
the database are related to a fixed amount of RNA col-
lected per sample. Variations in RNA yield across samples
in an experimental series compromise accurate determi-
nation of the absolute level of each mRNA species per cell
in any sample. Normalization against housekeeping
genes for PCRs, and global normalization of ratiometric
data for microarrays, is typically performed to account for
this informational loss. Additional methods, such as the
use of external mRNA spikes, reportedly improve the
quality of data from microarray systems. For example,
Holstege et al. [1] described a spike method against total
RNA, based on their finding that the yields of total RNA
from wild type and mutant cells were very similar. Hill et
al. [2] reported a spike method against total RNA for nor-
malizing hybridization data such that the sensitivities of
individual arrays could be compared. Lee et al. [3] demon-
strated that "housekeeping genes" cannot be used as a ref-
erence control, and van de Peppel et al. [4] described a
normalization method of mRNA against total RNA using
an external spike mixture. To achieve satisfactory perform-
ance they used multiple graded doses of external spikes,
covering a wide range of expression, in order to align the
ratiometric data by Lowess normalization [5]. Hekstra et
al. [6] presented a method for calculating the final cRNA
concentration in a hybridization solution. Sterrenburg et
al. [7] and Dudley et al. [8] reported the use of common
reference control samples for two-color microarray analy-
ses of the human and yeast genomes, respectively. These
are pools of antisense oligo sequences against all sense
oligos present on the microarray. Instead of antisense oli-
gos, Talaat et al. [9] used genomic DNA as a common ref-
erence control in studies of E. coli. Statistical approaches
have been proposed for ratiometric data to improve inter-
microarray variations, especially of non-linear relations
[10]. However, because control samples may differ among
studies, ratiometric data cannot easily be compared across
multiple studies unless a common reference, such as a
mixture of all antisense counterparts of spotted sense
sequences is used [7-9]. Nevertheless, as long as the nor-
malization is calibrated to total RNA, variations in total
RNA profile cannot be effectively cancelled out. Although
Dose-response linearity check by LBM Figure 1
Dose-response linearity check by LBM. Dose-response linearity of the Affymetrix GeneChip by the LBM (liver-brain mix) 
sample set. Five samples, i.e. mixtures of mouse liver and brain at ratios of 100:0, 75:25, 50:50, 25:75 and 0:100, were spiked 
with GSC and measured by Affymetrix GeneChips Mouse430-2. Signals were normalized by the Percellome method as 
described in the text. Line graphs are in (a) copy numbers and (b) ratio to 50:50 sample for the top 1,000 probe sets with coef-
ficient of correlation (R2) closest to 1 among those having 1 copy or more per cell in the 50:50 sample (19,979 probe sets out 
of 45,101). The number of probe sets with R2 > 0.950 was 8,655, and R2 > 0.900 was 11,719.
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some of these reports share the idea that "absolute expres-
sion" and "transcripts per cell" should entail robust nor-
malization, further practical development to enable
universal application has been awaited.
Here, we report a method for normalizing expression data
across samples and methods to the cell number of each
sample, using the DNA content as indicator. This normal-
ization method is independent of the gene expression
profile of the sample, and may contribute to transcrip-
tome studies as a common standard for data comparison
and interchange.
Results
Dose-response linearity of the measurement system as a 
basis for the Percellome method
The fidelity of transcript detection is the key to this "per
cell" based normalization method, which generates tran-
scriptome data in "mRNA copy numbers per cell". The Q-
PCR system was tested by serially diluting samples to con-
firm the linear relationship between Ct values and the log
of sample mRNA concentration (data not shown). High
density oligonucleotide microarrays from Affymetrix [11]
were used in our experiments. We tested the linearity of
the Affymetrix GeneChips using a set of five samples made
of mixtures of liver and brain in ratios of 100:0, 75:25,
50:50, 25:75, and 0:100 (designated "LBM" for liver-brain
mix). The results showed a linear relationship (R2 > 0.90)
between fluorescence intensity and input for a sufficient
proportion of probe sets, i.e. about 37% of the probe sets
in the older MG-U74v2 and 70% in the newest Mouse
Genome 430 2.0 GeneChip were above the detection level
(approximately one copy per cell) in the 50:50 sample
(Figure 1) [see Additional files 1 and 2].
Dose-response linearity alone is not sufficient to generate
true mRNA copy numbers. An important additional
requirement is that the ratio of signal intensity to mRNA
copy number should be equal among all GeneChip probe
sets of mRNAs and PCR primers. The Q-PCR primer sets
were designed to perform at similar amplification rates to
minimize differences between amplicons. The melting
Cross-hybridization of GSC Figure 2
Cross-hybridization of GSC. Cross-hybridization of the GSC spike mRNAs to Affymetrix GeneChip. (a) A scatter plot of a 
blank sample with the GSC (horizontal axis) and a blank with the five spike RNAs at a high dosage (vertical axis) measured by 
MG-U74v2A GeneChips (raw values generated by Affymetrix MAS 5.0 software). The five spikes are indicated by black dots 
with arrows. Signals of the murine probe sets were below 20 on the horizontal axis, indicating negligible cross-hybridization of 
GSC spike mRNAs to the murine probe sets. (b) A scatter plot of a liver sample with GSC (horizontal axis) and without GSC 
(vertical axis) measured by MG-U74v2A GeneChips. The five spikes are again indicated by black dots with arrows. The dotted 
line is the 1/25 fold (4%) line. Cross-hybridization of mouse liver mRNAs to the GSC signals was considered negligible (less 
than 4%).
(a) (b)
Liver sample 
with GSC
L
i
v
e
r
 
s
a
m
p
l
e
 
w
i
t
h
o
u
t
 
G
S
C
GSC alone   
F
i
v
e
 
s
p
i
k
e
s
 
a
t
 
h
i
g
h
 
d
o
s
e
 BMC Genomics 2006, 7:64 http://www.biomedcentral.com/1471-2164/7/64
Page 4 of 14
(page number not for citation purposes)
temperature was set between 60° and 65°C with a prod-
uct size of approximately 100 base pairs using an algo-
rithm (nearest neighbor method, TAKARA BIO Inc.,
Japan), and the amplification co-efficiency (E) was set
within the range 0.9 ± 0.1 (E = 2^{-(1/slope)}-1 on a plot
of log2 (template) against Ct value). For the GeneChip
system, the signal/copy performance of each probe set
depended on the strategy of designing the probes to keep
the hybridization constant/melting temperature within a
narrow range, ensuring that the dose-response perform-
ances of the probe sets were similar (cf. http://
www.affymetrix.com/technology/design/index.affx). Fail-
ing this, any differences should at least be kept constant
within the same make/version of the GeneChip. Taking
into consideration the biases that lead to imperfections in
estimating absolute copy numbers in each gene/probe set,
we developed normalization methods to set up a com-
mon scale for Q-PCR and Affymetrix GeneChip systems.
The grade-dosed spike cocktail (GSC) and the "spike 
factor" for the Percellome method
A set of external spike mRNAs was used to transfer the
measurement of cell number in the sample (as reflected
by its DNA content) to transcriptome analysis. For the
spikes, we utilized five Bacillus subtilis mRNAs that were
left open for users in the Affymetrix GeneChip series. The
extent to which the Bacillus RNAs cross-hybridized with
other probe sets was checked for the Affymetrix GeneChip
system. The GSC was applied to Murine Genome U74Av2
Array (MG-U74v2) GeneChips with or without a liver
sample. As shown in Figure 2, cross-hybridization
between Bacillus RNAs and the murine gene probe sets
was negligible [see Additional files 3 and 4]. Mouse
Genome 430 2.0 Array (Mouse430-2), Mouse Expression
Arrays 430A (MOE430A) and B (MOE430B), Rat Expres-
sion Array 230A (RAE230A), Xenopus laevis Genome Array
and Human Genome U95Av2 (HG-U95Av2) and U133A
(HG-U133A) Arrays sharing the same probe sets for these
spike mRNAs showed no sign of cross-hybridization with
the Bacillus probes (data not shown).
We prepared a cocktail containing in vitro transcribed
Bacillus mRNAs in threefold concentration steps, i.e.
777.6 pM (for AFFX-ThrX-3_at), 259.4 pM (for AFFX-
LysX-3_at), 86.4 pM (for AFFX-PheX-3_at), 28.8 pM (for
AFFX-DapX-3_at) and 9.6 pM (for AFFX-TrpnX-3_at). By
referring to the amount of DNA in a diploid cell and
employing a "spike factor" determined by the ratio of
Table 1: The spike factors for various organs/tissues
Species Organ/Tissue (adult, unless otherwise noted) Spike Factor total RNA/genomic DNA SD
Mouse Liver 0.2 211 46
Mouse Lung 0.02 22 4
Mouse Heart 0.05 - -
Mouse Thymus 0.01 8 2
Mouse Colon Epitherium 0.05 105 30
Mouse Kidney 0.1 - -
Mouse Brain 0.1 - -
Mouse Suprachiasmatic nucleus (SCN) 0.1 - -
Mouse Hypothalamus 0.1 63 4
Mouse Pituitary 0.1 52 8
Mouse Ovary 0.02 35 4
Mouse Uterus 0.02 42 12
Mouse Vagina 0.02 81 38
Mouse Testis 0.15 56 7
Mouse Epididymis 0.07 53 16
Mouse Bone marrow 0.02 14 3
Mouse Spleen 0.02 - -
Mouse Whole Embryo 0.15 97 36
Mouse Fetal Telencephalon E10.5–16.5 0.1 48 9
Mouse Neurosphere (E11.5–14.5) 0.03 42 10
Mouse E9.5 embryo heart 0.15 58 15
Mouse cell lines 0.2 - -
Rat Liver 0.2 - -
Rat Kidney 0.2 - -
Rat Uterus 0.04 56 5
Rat Ovary 0.04 56 9
Human Cancer Cell Lines 0.2 116 26
Xenopus liver 0.03 - -
Xenopus embryo 0.15 - -BMC Genomics 2006, 7:64 http://www.biomedcentral.com/1471-2164/7/64
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total RNA to genomic DNA in a tissue type (Table 1), the
spike mRNAs were calculated to correspond to 468.1,
156.0, 52.0, 17.3 and 5.8 copies per cell (diploid), respec-
tively, for the mouse liver samples (spike factor = 0.2). The
ratio of mRNAs in the cocktail is empirically chosen
depending on the linear range of the measurement system
and the available number of spikes. Here, we set the ratio
to three to cover the "present" call probe sets of the
Affymetrix GeneChip system (Figure 3).
We tested this grade-dosed spike cocktail (GSC) by Q-PCR
and confirmed that the Ct values of the spike mRNAs were
linearly related to the log concentrations (cf. Figure 4a),
i.e. could be expressed as
Ct = αlog C + β   {1}
The GSC was also tested by the GeneChip system and it
was confirmed that the log of the spike mRNA signal
intensities was linearly related to the log of their concen-
trations (cf. Figure 4b),
log S = γlog C + δ   {2}
The linear relationship between the Ct values (Ct) and the
log of RNA concentration (log C) was reasonable given
the definition of Ct values (derived from the number of
PCR cycles, i.e. doubling processes). The linear relation-
ship between the log of GeneChip signal intensity (log S)
and the log of RNA concentration (log C) was rationalized
by the near-normal distribution of log S over all tran-
scripts (cf. Figure 3).
Calculation of copy numbers of all genes/probe sets per 
cell
As described above, using a combination of DNA content
and the spike factor of the sample, the GSC spike mRNAs
become direct indicators of the copy numbers (C') per
cell. When the samples were measured by Q-PCR or Gene-
Chip analysis, the five GSC spike signals in each sample
should obey function {1} for Q-PCR and function {2} for
GeneChip with a good linearity. If the observed linearity
was poor, a series of quality controls was performed and
the measurement repeated. The coefficients of the func-
tions were determined for each sample by the least
squares method. Under the assumption that all genes/
probe sets share the same signal/copy relationship, signal
data for all genes/probe sets were fitted to the functions
{1'} or {2'}, which are the individualized functions of
{1} and {2} for each sample measurement (i).
Ct = αi log(C') + βi   {1'}
Log (S) = γi log(C') + δi {2'}
(i = sample measurement no.)
The Q-PCR Ct values (Ct) and microarray signal values (S)
of all mRNA species in the sample (i) are converted to
copy numbers per cell (C') by the inverses of functions
{1'} and {2'}, i.e. {3} and {4} below:
C' = B^((Ct-βi)/αi)   {3}
for Q-PCR (Figure 4a).;
C' = B^((logS-γi)/δi)   {4}
for GeneChips (Figure 4b),
where B is the logarithmic base used in {1} and {2} (see
Materials and Methods for details).
Real world performance of the Percellome method
The correspondence between Q-PCR and GeneChip was
tested using a sample set from 2,3,7,8-tetrachlorodiben-
zodioxin (TCDD)-treated mice. Sixty male C57BL/6 mice
Positioning of GSC spike mRNAs in Affymetrix GeneChip  dose-response range Figure 3
Positioning of GSC spike mRNAs in Affymetrix 
GeneChip dose-response range. A frequency histogram 
of the probe sets of Affymetrix GeneChip Mouse430-2 is 
shown. The histogram for all probe sets (gray) shows near-
normal distribution. Blue columns are the "present" calls (P), 
red columns "absent" calls (A) and green "marginal" calls. The 
five yellow lines indicate the positions of the GSC spike 
mRNAs that are chosen to cover the "present" call range by 
a proper "spike factor".
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were divided into 20 groups of 3 mice each. TCDD was
administered once orally at doses of 0, 1, 3, 10 and 30 µg/
kg, and the livers were sampled 2, 4, 8 and 24 h after
administration. Nineteen primer pairs were prepared for
Q-PCR and the Ct values of the liver transcriptome were
measured. The same 60 liver samples were measured
using the Affymetrix Mouse430-2 GeneChip [see Addi-
tional files 5 through 8 and 9 through 12]. Q-PCR and
GeneChip data were normalized against cell number by
functions {3} and {4}, respectively. The averages and
standard deviations (sd) of each group (n = 3) were calcu-
lated and plotted as three layers of isoborograms on to 5
× 4 matrix three-dimensional graphs (Figure 5). Together
with another sample set (data not shown), a total of
thirty-six primer pairs were compared, and there was a
correlation of up to 90% between the Q-PCR and Gene-
Chip surfaces. It is notable that not only the average sur-
faces but also the +1sd and -1sd surfaces corresponded
closely in shape and size. We infer that the differences
resulted mainly from biological variations among the
three animals in each experimental group rather than
from measurement error (cf. Figure 7).
An important feature of Percellome normalization is its
independence from the overall expression profile of the
sample. When gene expression profiles differ among sam-
ples, Percellome normalization produces a robust tran-
scriptome that is different from total-RNA dependent
global normalization. As an example, Figure 6 shows the
results of an experiment on the uterotrophic response of
ovariectomized mice to estrogen treatment [12] [see Addi-
tional files 13 and 14]. The uteri of the vehicle control are
atrophic because the ovaries, the source of intrinsic estro-
gens, are absent. The uteri of the treated groups are hyper-
trophic owing to estrogenic stimulus from the test
compound administered. Global normalization (90 per-
centile) between the vehicle control group and the high-
dose (1,000 mg/kg) group indicated that 4,600 of 12,000
probe sets showed 2-fold or greater increase, 470 were
reduced by 0.5 or less, and 7,400 remained between these
extremes. In contrast, analysis of Percellome-normalized
data revealed that almost all the 12,000 probe sets showed
a 2-fold or greater increase, including actin, GAPDH and
other housekeeping genes. The hypertrophic tissues, con-
sisting of cells with abundant cytoplasm, provide convinc-
ing evidence for the increases in various cellular
components including housekeeping gene products.
Another important feature of Percellome normalization is
the commonality of the expression scale across platforms.
Batch conversion can be performed between results
obtained from different platforms when the data are gen-
erated by the Percellome method. A practical strategy for
such normalization is to prepare a set of samples from a
target organ of interest with differences in gene expres-
sion, and measure them once by each platform. Data con-
version functions with good linear dose-response
relationships can be obtained individually for those
genes/probe sets that are measured by both platforms
(Figure 7).
Discussion
We have developed a novel method for normalizing
mRNA expression values to sample cell numbers by add-
ing external spike mRNAs to the sample in proportion to
the genomic DNA concentration. For non-diploid or ane-
uploid samples, an average DNA content per cell should
be determined beforehand for accurate adjustment. When
there is significant DNA synthesis, a similar adjustment
should be considered.
The dose-response linearity of the GSC spikes in Q-PCR and  the Affymetrix GeneChip array system Figure 4
The dose-response linearity of the GSC spikes in Q-
PCR and the Affymetrix GeneChip array system. Lin-
ear relationships are shown between (a) the Q-PCR Ct val-
ues and log of copy number (log (C')), and (b) the GeneChip 
log signal intensity (log(S)) and log of copy number (log (C')) 
of the GSC mRNAs. The regression functions were obtained 
by the least squares method. The inverse functions (*) were 
further used to generate the copy numbers of all other 
genes/probe sets for Percellome normalization.
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The smallest sample to which we have successfully
applied the direct DNA quantification method with suffi-
cient reproducibility is the 6.75 dpc (days post coitus)
mouse embryo which consists of approximately 5,000
cells. This sample size is also approximately the lower
limit for double amplification protocol to obtain suffi-
cient amount of RNA for Affymetrix GeneChip measure-
ment (cf. http://www.affymetrix.com/Auth/support/
downloads/manuals/expression_print_manual.zip.)
High-resolution technology such as laser-capture micro-
dissection (LCM) has become popular and the average
sample size analyzed is getting smaller. An alternative
method for LCM samples is to count the cell number in
the course of microdissection. Although we have not yet
applied Percellome method to LCM samples, we have
applied the alternative method to cell culture samples to
gain Percellome data. Stereological and statistical calcula-
tions should become available to correct the number of
partially sectioned cells in the LCM samples. Another
issue for small samples is the yield of RNA. Approximately
Correspondence between Q-PCR and GeneChip data Figure 5
Correspondence between Q-PCR and GeneChip data. Sixty male C57BL/6 mice were divided into 20 groups of 3 mice 
each. 2,3,7,8-tetrachlorodibenzodioxin (TCDD) was administered once orally at doses of 0, 1, 3, 10 and 30µg/kg, and the liver 
was sampled 2, 4, 8 and 24 h after administration. The liver transcriptome was measured by the Affymetrix Mouse430-2 Gene-
Chip. For Q-PCR, nineteen primary pairs were prepared and the Ct values of the same 60 liver samples were measured (19 
genes and 5 spikes in duplicate, using a 96-well plate for 2 samples, total 30 plates). The Percellome data were plotted on to 3-
dimensional graphs for average, +1sd, and – 1sd surfaces as shown in (a). The scale of expression (vertical axis) is the copy 
number per cell. The 0 h data (*) are copied from the 2 h/dose 0 point for better visualization of the changes after 2 h. The sur-
faces are demonstrated as a grid plot (b) where the grid points indicate one treatment group (n = 3), and a smoothened spline 
surface plot (c) for easier 3D recognition ((b), (c): Gys2 (glycogen synthase 2, 1424815_ at) showing a typical circadian pattern. 
(d) the smoothened plots of 6 representative genes/ probe sets generated by Q-PCR (red) and GeneChip (blue). AhR (arylhy-
drocarbon receptor, 1450695_at)  showed imperfect correspondence. Cyp1a1 (cytochrome P450, family 1, subfamily a, 
polypeptide 1, 1422217_a_at) and Cyp1a2 (1450715_at) showed good correlations between Q-PCR and GeneChip except for 
the saturation in GeneChips above c. 400 copies per cell. Cyp1b1 (1416612_at) and Cyp7a1 (1422100_at) showed good corre-
spondence. Hspa1a (heat shock protein 1A, 1452888_at) showed fair correspondence despite low copy numbers, near the 
nominal detection limit of the Affymetrix GeneChip system.
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30 ng of total RNA is retrieved from a single 6.75 dpc
mouse embryo. This amount is sufficient for a double
amplification protocol (DA) to prepare enough RNA for
an Affymetrix GeneChip measurement. An inherent prob-
lem with the DA data is that the gene expression profile
differs from that of the default single amplification proto-
col (SA). Consequently the DA percellome data differ
from that of SA as if they were produced by a different
platform. To bridge the difference, we applied the proce-
dure that was used for data conversion between Q-PCR
and GeneChip (cf. Figure 7). A set of spiked-in standard
samples including the LBM sample set (of sufficient con-
centration) were measured by the SA protocol and diluted
versions to the limit measured by the DA protocol. These
data provided us with information about whether DA was
successful as a whole (by comparing 5' signal to 3' signals
of selected probe sets) and which probe sets were properly
amplified by DA (by checking the linearity of the diluted
LBM data). For those probe sets that proved to be linearly
amplified, conversion functions between DA and SA were
generated. These details, along with embryo expression
data will be published elsewhere.
Figures 5 and 7 indicate a close correspondence between
the data generated by Q-PCR and GeneChip analyses.
Since each of the 60 samples was normalized individually
against each GSC signal, the high similarity between the
two platforms indicates the robustness and stability of
this spike system (cf. Figure 7, Cyp7a1 data). Although
more spikes could potentially increase the accuracy of
normalization, our experience is that five spikes are prac-
tically sufficient for covering the detection range of Gene-
Chip microarrays and Q-PCR, as long as they are used in
combination with the "spike factor". The overall benefits
of using a minimum number of external spikes include
lower probability of cross-hybridization, a reduced
number of wells and spots occupied by the spikes in the
Q-PCR plates and small scale microarrays, and less effort
in preparation, QC and supply.
The Percellome data can be truly absolute when all mRNA
measurements including GSC spikes are strictly propor-
tional to the original copy numbers in the sample
homogenate. As noted earlier, this condition is not guar-
anteed by any platform despite linearity of response.
Therefore, the Percellome-normalized values have some
biases for each primer pair/probe set, depending on the
steepness of the dose-response curves. An advantage of
Percellome normalization is that, as long as such biases
are consistently reproduced within a platform, the data
can be compared directly among samples/studies on a
common scale. Consequently, when a true value is
obtained by any other measure, all the data obtained in
the past can be simultaneously batch-converted to the true
values.
This batch-conversion strategy can be extended to data
conversion between different versions and different plat-
forms, as long as the data are generated in copy numbers
"per cell". We have shown an example between Affymetrix
GeneChip and Q-PCR for limited numbers of probe sets
(cf. Figure 7). Custom microarrays that accept our GSC for
Percellome normalization are in preparation by Agilent
Technologies (single color) and GE Healthcare (CodeLink
Bioarray).
Uterotrophic response of ovariectomized female mice by an  estrogenic test compound Figure 6
Uterotrophic response of ovariectomized female 
mice by an estrogenic test compound.(a) Shows the 
uterine weight, which increases in a dose-dependent manner; 
V, vehicle control; Low, low dose; ML, medium-low dose; 
MH, medium-high dose; High, high dose group. (b) Shows the 
line display of uterine gene expression (Affymetrix MG-
U74v2 A GeneChips) normalized by global normalization (90 
percentile), and (c) by the Percellome normalization. Aver-
ages of three samples per group were visualized (by K. A.). 
The five white lines are the GSC mRNAs. The green and blue 
lines are actin (AFFX-b-ActinMur/M12481_3_at) and 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase, AFFX- 
GapdhMur/M32599_3_at), respectively. By global normaliza-
tion, 7,400 probe sets remained unchanged and 4,600 probe 
sets increased more than two-fold in the H group compared 
to the V group, whereas almost all probe sets measured had 
increased. It is noted that housekeeping genes such as actin 
and GAPDH are significantly induced on a per cell basis.
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Another important contribution of Percellome analysis is
in the area of archived data in private and public domains.
Firstly, Percellome data are the result of a simple linear
transformation of the raw microarray data; preserving the
distribution and order of the probe set data. Therefore,
parametric or non-parametric methods should be able to
align the data distribution and generate estimates of
mRNA copy number of the non-spiked archival samples.
Any archival samples that are re-measurable by Percel-
lome method will greatly increase the accuracy of estima-
tion. Secondly, percellome can provide appropriate
bridging information between old and new versions of
Affymetrix GeneChips, such as human HU-95 and HU-
133, murine MU-74v2 and MOE430 series. This should
also facilitate comparisons between newly generated and
archived data.
Conversion functions between Q-PCR and GeneChip Figure 7
Conversion functions between Q-PCR and GeneChip. The data shown in Figure 5 as 3D surfaces are shown as a scatter 
plot (60 plots). The regression function can be used to convert Q-PCR to GeneChip and vice versa, with a level of certainty 
indicated by coefficient of correlation. It is noted that Cyp1a1 and Cyp1a2 became saturated above about 400 copies per cell in 
GeneChip system (indicated in pink plots). Cyp7a1 showed high linearity, indicating that the variation shown by the split +1sd 
and -1sd surfaces in Figure 5 reflected biological (animal) variation, not measurement errors.
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The Percellome method was developed for a large-scale
toxicogenomics project [13] using the Affymetrix Gene-
Chip system. It was intended to compile a very large-scale
database of comprehensive gene expression profiles in
response to various chemicals from a series of experi-
ments conducted over an extended time period. However,
the method also proved to be useful for small-scale plat-
forms such as 96 well plate-based Q-PCRs as shown
above, and probably for small-scale targeted microarrays.
In both cases, highly inducible or highly transcribed genes
are likely to be selected. Therefore, the expression profiles
may differ significantly among samples such that profile-
dependent normalization (e.g. global normalization)
may not be applicable. In such cases, the profile-inde-
pendent nature of the Percellome method provides a
robust normalization.
To demonstrate the profile-independence of the Percel-
lome method, we chose an extreme case – the utero-
trophic response assay (cf. Figure 6). The treated uteri
were composed of hypertrophic cells with abundant cyto-
plasm whereas the untreated uteri were composed of
hypoplastic cells with scant cytoplasm. This indicates that
the uteri of untreated ovariectomized mice were quies-
cent, and that a majority of the inducible genes were prob-
ably transcriptionally inactive. Therefore, the
identification of most genes as being induced by 2-fold or
greater is reasonable and expected. In most in vivo experi-
ments, the gene profiles of the samples are much more
similar. However, there is always a set of genes that is
found to be "increased" when analyzed on a "per one cell"
basis that are declared to be "decreased" by global type
normalization, or vice versa. Such increase/decrease calls
made by the global type normalization can differ accord-
ing to the normalization parameters. In both cases, the
Percellome method can inform the researcher how much
the expression profiles are distorted by the treatment, such
as in the case of the uterotrophic assay. We also note that
in vitro experiments such as cell-based studies tend to gen-
erate data similar to that of uterotrophic experiment.
Conclusion
Percellome data can be compared directly among samples
and among different studies, and between different plat-
forms, without further normalization. Therefore, "percel-
lome" normalization can serve as a standard method for
exchanging and comparing data across different platforms
and among different laboratories. We hope that the Per-
cellome method will contribute to transcriptome-based
studies by facilitating data exchanges among laboratories.
Methods
Animal experiments
C57BL/6 Cr Slc (SLC, Hamamatsu, Japan) mice main-
tained in a barrier system with a 12 h photoperiod were
used in this study. For the liver transcriptome experi-
ments, twelve week-old male mice were given a single
dose of the test compound by oral gavage, and the liver
was sampled at 2, 4, 8 and 24 h post-gavage. For the uter-
otrophic experiment, 6 week old female mice were ova-
riectomized 14 days prior to the 7 day repeated
subcutaneous injection of a test compound [12]. Animals
were euthanized by exsanguination under ether anesthe-
sia and the target organs were excised into ice-cooled plas-
tic dishes. Tissue blocks weighing 30 to 60 mg were placed
in an RNase-free 2 ml plastic tube (Eppendorf GmbH.,
Germany) and soaked in RNAlater (Ambion Inc., TX)
within 3 min of the beginning of anesthesia. Three ani-
mals per treatment group were used and individually sub-
jected to transcriptome measurement.
Sample homogenate preparation
The tissue blocks soaked in RNAlater were kept overnight
at 4°C or until use. RNAlater was replaced in the 2 ml
plastic tube with 1.0 ml of RLT buffer (Qiagen GmbH.,
Germany), and the tissue was homogenized by adding a 5
mm diameter Zirconium bead (Funakoshi, Japan) and
shaking with a MixerMill 300 (Qiagen GmbH., Germany)
at a speed of 20 Hz for 5 min (only the outermost row of
the shaker box was used).
Direct DNA quantitation
Three separate 10 µl aliquots were taken from each sample
homogenate to another tube and mixed thoroughly. A
final 10 µl aliquot therefrom was treated with DNAse-free
RNase A (Nippon Gene Inc., Japan) for 30 min at 37°C,
followed by Proteinase K (Roche Diagnostics GmbH.,
Germany) for 3 h at 55°C in 1.5 ml capped tubes. The
aliquot was transferred to a 96-well black plate. PicoGreen
fluorescent dye (Molecular Probes Inc., USA) was added
to each well, shaken for 10 seconds four times and then
incubated for 2 min at 30°C. The DNA concentration was
measured using a 96 well fluorescence plate reader with
excitation at 485 nm and emission at 538 nm. λ phage
DNA (PicoGreen Kit, Molecular Probes Inc., USA) was
used as standard. Measurement by this PicoGreen method
and the standard phenol extraction method correlated
well (coefficient of correlation = 0.97, data not shown).
The smallest sample size for reproducible and reliable
DNA quantitation is about 5,000 cells that corresponds to
a 6.75 dpc mouse embryo.
The grade-dosed spike cocktail (GSC)
The following five Bacillus subtilis RNA sequences were
selected from the gene list of Affymetrix GeneChip arrays
(AFFX-ThrX-3_at, AFFX-LysX-3_at, AFFX-PheX-3_at,
AFFX-DapX-3_at, and AFFX-TrpnX-3_at) present in the
MG-U74v2, RG-U34, HG-U95, HG-U133, RAE230 and
MOE430 arrays: thrC, thrB genes corresponding to nucle-
otides 248–2229 of X04603; lys gene for diami-BMC Genomics 2006, 7:64 http://www.biomedcentral.com/1471-2164/7/64
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nopimelate decarboxylase corresponding to nucleotides
350–1345 of X17013; pheB, pheA genes corresponding to
nucleotides 2017–3334 of M24537, dapB, jojF, jojG
genes corresponding to nucleotides 1358–3197 of
L38424; TrpE protein, TrpD protein, TrpC protein corre-
sponding to nucleotides 1883–4400 of K01391. The cor-
responding cDNAs were purchased from ATCC,
incorporated into expression vectors, amplified in E. coli
and transcribed using the MEGAscript kit (Ambion Inc.,
TX). The mRNA was purified using a MACS mRNA isola-
tion kit (Miltenyi Biotec GmbH., Germany). The concen-
trations of spike RNAs in the GSC were in threefold steps,
from 777.6 pM for AFFX-ThrX-3_at, 259.4 pM for AFFX-
LysX-3_at, 86.4 pM for AFFX-PheX-3_at, 28.8 pM for
AFFX-DapX-3_at, to 9.6 pM for AFFX-TrpnX-3_at. In gen-
eral, the ratio depends on the linear range of the measure-
ment system and the available number of spikes.
Setting of the "spike factor" and addition of GSC to a 
sample homogenate according to its DNA concentration
The GSC was added to the sample homogenates in pro-
portion to their DNA concentrations, assuming that all
cells contain a fixed amount of genomic DNA (g/cell)
across samples. The amount of GSC added to each sample
G (l) was given as
G = C * v * f   (l),
where C is the DNA concentration (g/l), v(l) is the volume
of homogenate further used for RNA extraction and f (l/g)
is the "spike factor", which is an adjustment factor to
ensure that the sample is properly spiked by the GSC (cf.
Figure 3). Spike factors have been pre-determined for var-
ious organs/tissues to reflect differences in their total
RNA/genomic DNA ratios (cf. Table 1). In this way, five
spike mRNA signals can properly cover the linear dose-
response range of the platform. In practice, for the
Affymetrix GeneChips, the spike factor is set so that the
five GSC spikes cover the range of "Present" calls given by
the Affymetrix system, which corresponds to approxi-
mately 80 to 7000 in raw readouts given by the Affymetrix
MAS5.0 software. A raw readout of 10 by the current
Affymetrix GeneChip system corresponds to approxi-
mately one copy per cell in mouse liver (spike factor =
0.2), whereas in mouse thymus (spike factor = 0.01) it
corresponds to approximately 0.05 copy per cell. For Q-
PCR, the same spike factor corresponds to Ct values rang-
ing approximately from 17 to 27, which is well within the
linear range of Q-PCR (data not shown).
"Per cell" normalization (Percellome normalization)
Since murine haploid genomic DNA is made of 2.5 × 109
base pairs and one base pair is approximately 600 Daltons
(Da), the haploid genomic DNA weighs 1.5 × 1012 Da,
corresponding to
d = 5 × 10-12 (g DNA per diploid cell).
Therefore, the cell number per liter of the sample
homogenate (N) is given as
N = C/d (cells/l)
where C is the DNA concentration (g/l).
On the other hand, the copy numbers of GSC RNAs in the
homogenate are given as follows:
if Sj (mole/l) (j = 1,2,3,4,5) is the mole concentration of
one of the five spike RNAs in the GSC solution and G(l) is
the amount of GSC added to each homogenate, the mole
concentrations of the spike RNAs in the homogenate
(CSj) are given as,
CSj = Sj*C*f (mole/l).
The GSC RNAs in moles per cell (MSj) are given as
MSj = CSj/N
= Sj*C*f/(C/d)
= Sj*f*d (mole/cell)
The copy numbers of the GSC RNAs per cell (NSj) are
given as
NSj = MSj*A
= Sj*f*d*A (copies per diploid cell)
where A is Avogadro's number.
As a result, the GSC spikes AFFX-TrpnX-3_at, AFFX-DapX-
3_at, AFFX-PheX-3_at, AFFX-LysX-3_at and AFFX-ThrX-
3_at correspond approximately to 5.8, 17.3, 52.0, 156.0
and 468.1 copies per cell (per diploid DNA template) for
mouse liver sample homogenates, where the spike factor
= 0.2. It is our observation that the RNA/DNA ratios are
virtually constant across polyploid hepatocytes (data not
shown).
For each Q-PCR plate or GeneChip, the coefficients, α, β,
γ and δ of functions {1} or {2} are determined from the
GSC values using the least-square method. The signal val-
ues or Ct values of all the other mRNAs measured are then
converted to copy numbers per cell by {3} or {4}, i.e. the
inverses of functions {1} or {2}.BMC Genomics 2006, 7:64 http://www.biomedcentral.com/1471-2164/7/64
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The "LBM" ("liver-brain mix") standard sample
A pair of samples having dissimilar gene expression pro-
files was chosen to evaluate the linearity of the platform.
The pairs chosen were brain and liver for mouse and rat,
two distinct cancer cell lines for humans, and adult liver
and embryo for Xenopus laevis. The sample pairs were
processed as described above including addition of the
GSC. Two final homogenates were then blended at ratios
of 100:0, 75:25, 50:50, 25:75 and 0:100 (based on cell
numbers) to make five samples. These five samples were
measured by Q-PCR and/or GeneChips (MG-U74v2A,
MEA430A, MEA430B, MG430 2.0 (shown in Figure 1),
RAE230A, HG-U95A, HG-U133, and Xenopus array).
Quantitative-PCR
Duplicate homogenate samples were treated with DNaseI
(amplification grade, Invitrogen Corp., Carlsbad, CA,
USA) for 15 min at room temperature, followed by Super-
Script II (Invitrogen) for 50 min at 42°C for reverse tran-
scription. Quantitative real time PCR was performed with
an ABI PRISM 7900 HT sequence detection system
(Applied Biosystems, Foster City, CA, USA) using SYBR
Premix Ex Taq (TAKARA BIO Inc., Japan), with initial
denaturation at 95°C for 10 s followed by 45 cycles of 5 s
at 95°C and 60 s at 60°C, and Ct values were obtained.
Primers for the genes explored in this study were selected
from sequences close to the areas of Affymetrix GeneChip
probe sets as shown in Table 2.
Affymetrix GeneChip measurement
The sample homogenates with GSC added were processed
by the Affymetrix Standard protocol. The GeneChips used
were MG-U74v2A for the uterotrophic study and Mouse
430-2 for the TCDD study (singlet measurement). The
efficiency of in vitro transcription (IVT) was monitored by
comparing the values of 5' probe sets and 3' probe sets of
the control RNAs (AFFX- probe sets) including the GSC
(see Quality Control below). The dose-response linearity
of the five GSC spikes was checked and samples showing
saturation and/or high background were re-measured
from either backup tissue samples, an aliquot of homoge-
nate, or a hybridization solution, depending on the
nature of the anomaly.
Quality control
Any external spiking method, including our Percellome
method, is valid for high-quality RNA samples. Therefore,
the quality of the sample RNA should be carefully moni-
tored. In addition to a common checkup by RNA electro-
phoresis (including capillary electrophoresis if necessary),
OD ratio, and cRNA yield, we monitor the performance of
IVT (in vitro translation) or amplification. The 3' and 5'
probe set data of the spiked-in RNAs and sample RNAs
(actin, GAPD and other AFFX- probe sets) that are pre-
pared in Affymetrix GeneChip are compared to monitor
the extension of RNA by the IVT process. When both the
spiked-in RNAs and the sample RNAs have similar levels
of 5' and 3' signals respectively, it is judged that the IVT
extension was normally performed. When both spiked-in
and sample RNAs have significantly lower 5' signal than 3'
signal, it is judged that the IVT extension was abnormal.
When only the sample RNAs showed significantly lower 5'
signal than 3' signal, it is judged that the IVT extension
was normal but the sample RNAs were degraded. When
only the spiked-in RNAs showed significantly lower 5' sig-
nal than 3' signal, it is judged that the IVT extension was
normal but the spiked-in RNAs were degraded (although
we have not encountered this situation). In addition, if
the degraded sample was spiked-in by the non-degraded
spike RNAs and measured by GeneChip, the position of
spiked-in RNAs will be offset toward abnormally higher
intensity. Together, this battery of checkups considerably
increases the ability to detect abnormal events that will
affect the reliability of the Percellome method. When any
abnormality was found, each step of sample preparation
was reevaluated to regain normal data for Percellome nor-
malization.
Table 2: Primers for Q-PCR
Gene Forward Reverse
AFFX-TrpnX-3_at TTCTCAGCGTAAAGCAATCCA GCAAATCCTTTAGTGACCGAATACC
AFFX-DapX-3_at TCAGCTAACGCTTCCAGACC GGCCGACAGATTCTGATGACA
AFFX-PheX-3_at GCCAATGATATGGCAGCTTCTAC TGCGGCAGCATGACCATTA
AFFX-LysX-3_at CCGCTTCATGCCACTGAATAC CCGGTTCGATCCAAATTTCC
AFFX-ThrX-3_at CCTGCATGAGGATGACGAGA GGCATCGGCATATGGAAAC
Ahr_1450695_at CAGAGACCACTGACGGATGAA AGCCTCTCCGGTAGCAAACA
Cyp1a1_1422217_a_at TGCTCTTGCCACCTGCTGA GGAGCACCCTGTTTGTTTCTATG
Cyp1a2_1450715_at CCTCACTGAATGGCTTCCAC CGATGGCCGAGTTGTTATTG
Cyp1b1_1416612_at GCCTCAGGTGTGTTTGATGGA AGTACAGCCCTGGTGGGAATG
Cyp7a1_1422100_at TTCTACATGCCCTTTGGATCAG GGACACTTGGTGTGGCTCTC
Hspa1a_1452388_at ACCATCGAGGAGGTGGATTAGA AGGACTTGATTGCAGGACAAACBMC Genomics 2006, 7:64 http://www.biomedcentral.com/1471-2164/7/64
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The web site for GeneChip data
The GeneChip data are accessible at http://
www.nihs.go.jp/tox/TTG_Archive.htm.
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Additional material
Additional File 1
Excel spreadsheet file containing 15 Affymetrix Mouse 430–2 GeneChip 
raw data of five LBM samples in triplicate (cf. Figure 1). The column 
name LBM-100-0-X_Signal indicates the component percentages, i.e. 
100% liver 0% brain, and X = 1,2,3 indicates the triplicates. The LBM-
100-0-X_Detection column indicates P for present, A for absent and M 
for marginal calls by Affymetrix MAS 5.0 system.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S1.zip]
Additional File 2
Excel spreadsheet file containing Percellome data of the same LBM sam-
ples, of which raw data is listed in Additional file 1 (cf. Figure 1).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S2.zip]
Additional File 3
Excel spreadsheet file containing 2 Affymetrix MG-U74v2 raw data of a 
blank sample with the GSC (horizontal axis of Figure 2a) and blank with 
the five spike RNAs at a high dosage (vertical axis of Figure 2a).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S3.zip]
Additional File 4
Excel spreadsheet file containing 2 Affymetrix MG-U74v2 raw data of a 
liver sample with GSC (horizontal axis of Figure 2b) and without GSC 
(vertical axis of Figure 2b).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S4.zip]
Additional File 5
(first quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 2 hr data (15 GeneChip data) of the total of 60 Affymetrix 
Mouse 430-2 GeneChip raw data of the TCDD study consisting of 20 dif-
ferent treatment groups in triplicate (cf. Figure 5). The column name 
DoseXXX-TimeYY-Z_Signal indicates the dosage and sampling time after 
TCDD administration in hours, e.g. XXX = 001 indicates 1 microgram/
kg group, YY = 02 indicates two hours after administration, and Z = 1,2,3 
indicates animal triplicate. The DoseXXX-TimeYY-Z_Detection column 
indicates P for present, A for absent and M for marginal calls by Affyme-
trix MAS 5.0 system.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S5.zip]
Additional File 6
(second quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 4 hr data (15 GeneChip data) of the total of 60 Affymetrix 
Mouse 430-2 GeneChip raw data of the TCDD study consisting of 20 dif-
ferent treatment groups in triplicate (cf. Figure 5). The column name 
DoseXXX-TimeYY-Z_Signal indicates the dosage and sampling time after 
TCDD administration in hours, e.g. XXX = 001 indicates 1 microgram/
kg group, YY = 02 indicates two hours after administration, and Z = 1,2,3 
indicates animal triplicate. The DoseXXX-TimeYY-Z_Detection column 
indicates P for present, A for absent and M for marginal calls by Affyme-
trix MAS 5.0 system.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S6.zip]
Additional File 7
(third quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 8 hr data (15 GeneChip data) of the total of 60 Affymetrix 
Mouse 430-2 GeneChip raw data of the TCDD study consisting of 20 dif-
ferent treatment groups in triplicate (cf. Figure 5). The column name 
DoseXXX-TimeYY-Z_Signal indicates the dosage and sampling time after 
TCDD administration in hours, e.g. XXX = 001 indicates 1 microgram/
kg group, YY = 02 indicates two hours after administration, and Z = 1,2,3 
indicates animal triplicate. The DoseXXX-TimeYY-Z_Detection column 
indicates P for present, A for absent and M for marginal calls by Affyme-
trix MAS 5.0 system.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S7.zip]
Additional File 8
(last quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 24 hr data (15 GeneChip data) of the total of 60 Affyme-
trix Mouse 430-2 GeneChip raw data of the TCDD study consisting of 20 
different treatment groups in triplicate (cf. Figure 5). The column name 
DoseXXX-TimeYY-Z_Signal indicates the dosage and sampling time after 
TCDD administration in hours, e.g. XXX = 001 indicates 1 microgram/
kg group, YY = 02 indicates two hours after administration, and Z = 1,2,3 
indicates animal triplicate. The DoseXXX-TimeYY-Z_Detection column 
indicates P for present, A for absent and M for marginal calls by Affyme-
trix MAS 5.0 system.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S8.zip]BMC Genomics 2006, 7:64 http://www.biomedcentral.com/1471-2164/7/64
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Additional File 9
(first quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 2 hr Percellome data (15 sample data) of the 60 samples 
of the TCDD study (cf. Figure 5), of which corresponding raw data is 
listed in Additional file 5.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S9.zip]
Additional File 10
(second quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 4 hr Percellome data (15 sample data) of the 60 samples 
of the TCDD study (cf. Figure 5), of which corresponding raw data is 
listed in Additional file 6.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S10.zip]
Additional File 11
(third quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 8 hr Percellome data (15 sample data) of the 60 samples 
of the TCDD study (cf. Figure 5), of which corresponding raw data is 
listed in Additional file 7.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S11.zip]
Additional File 12
(last quarter of a data set consisting of 2 hr, 4 hr, 8 hr, and 24 hr data, 
divided because of the upload file size limitation)]: an Excel spreadsheet 
file containing 24 hr Percellome data (15 sample data) of the 60 samples 
of the TCDD study (cf. Figure 5), of which corresponding raw data is 
listed in Additional file 8.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S12.zip]
Additional File 13
Excel spreadsheet file containing 15 Affymetrix MG-U74v2 A GeneChip 
raw data of the uterotrophic response study (cf. Figure 6). The column 
name X-Y_Signal indicates the treatment (V = vehicle, Low = low dose, 
etc) and animal triplicate (Y = 1,2,3). The X-Y_Detection column indi-
cates P for present, A for absent and M for marginal calls by Affymetrix 
MAS 5.0 system.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S13.zip]
Additional File 14
Excel spreadsheet file containing Percellome data of the same 15 samples 
of the uterotrophic response study (cf. Figure 6), of which raw data is 
listed in Additional file 13.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-7-64-S14.zip]